全文获取类型
收费全文 | 11271篇 |
免费 | 1195篇 |
国内免费 | 339篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 233篇 |
妇产科学 | 68篇 |
基础医学 | 1346篇 |
口腔科学 | 332篇 |
临床医学 | 938篇 |
内科学 | 1633篇 |
皮肤病学 | 442篇 |
神经病学 | 1318篇 |
特种医学 | 1691篇 |
外国民族医学 | 2篇 |
外科学 | 761篇 |
综合类 | 894篇 |
预防医学 | 236篇 |
眼科学 | 161篇 |
药学 | 1471篇 |
1篇 | |
中国医学 | 492篇 |
肿瘤学 | 753篇 |
出版年
2024年 | 8篇 |
2023年 | 191篇 |
2022年 | 222篇 |
2021年 | 495篇 |
2020年 | 410篇 |
2019年 | 396篇 |
2018年 | 415篇 |
2017年 | 457篇 |
2016年 | 472篇 |
2015年 | 544篇 |
2014年 | 840篇 |
2013年 | 792篇 |
2012年 | 726篇 |
2011年 | 831篇 |
2010年 | 658篇 |
2009年 | 643篇 |
2008年 | 624篇 |
2007年 | 532篇 |
2006年 | 464篇 |
2005年 | 485篇 |
2004年 | 367篇 |
2003年 | 324篇 |
2002年 | 279篇 |
2001年 | 225篇 |
2000年 | 155篇 |
1999年 | 130篇 |
1998年 | 118篇 |
1997年 | 127篇 |
1996年 | 110篇 |
1995年 | 138篇 |
1994年 | 128篇 |
1993年 | 106篇 |
1992年 | 63篇 |
1991年 | 45篇 |
1990年 | 47篇 |
1989年 | 32篇 |
1988年 | 25篇 |
1987年 | 31篇 |
1986年 | 17篇 |
1985年 | 34篇 |
1984年 | 22篇 |
1983年 | 15篇 |
1982年 | 10篇 |
1981年 | 15篇 |
1980年 | 9篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1977年 | 2篇 |
1976年 | 6篇 |
1975年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《European journal of surgical oncology》2022,48(8):1713-1717
BackgroundLymphedema is a serious complication of axillary lymph node dissection (ALND) with an incidence rate of 20%. Simplified Lymphatic Microsurgical Preventing Healing Approach (SLYMPHA) is a safe and relatively simple method, which decreases incidence of lymphedema dramatically. Our initial study showed an 88% decrease in clinical lymphedema rate. In the initial study, we used arm circumference measurement for the diagnosis of lymphedema and median follow up was 15 months. The aim of this study was to confirm these results after a long-term follow up period and by using bioimpedance spectroscopy (L-Dex) technology in detecting lymphedema.Study designAll patients, undergoing ALND with or without SLYMPHA between January 2014 and November 2020 were included in the study. Patients with no postoperative L-Dex measurements were excluded. A L-Dex score outside the normal range (±10 L-Dex unit) or ≥10 L-Dex unit increase above patient's baseline was considered as lymphedema. The incidence of lymphedema was compared between patients with and without SLYMPHA.Results194 patients were included in the study. 57% of cohort underwent SLYMPHA. Mean follow-up time was 47 ± 37 months. Patients, who underwent SLYMPHA, had a significantly lower rate of lymphedema (16% vs 32%; p = 0.01; OR 0.4 [0.2–0.8]).ConclusionSLYMPHA is a safe and relatively simple method, which continued its efficacy after a long-term follow up period. It should be considered as an adjunct procedure to ALND for all patients during initial surgery. 相似文献
2.
3.
4.
Background:We aim to evaluate the efficiency of Raman spectroscopy (RS) in diagnosing suspected patients with intrahepatic cholangiocarcinoma (ICC), manifested by diagnostic sensitivity, specificity, and accuracy.Methods:We will research widely the articles concerning the use of RS in ICC through authenticated database including PubMed/Medline, EMBASE, Web of Science, Ovid, Web of Knowledge, Cochrane Library, and CNKI between January 2012 and November 2020, retrieving at least 1500 spectra with strict criteria. This study will be carried out in accordance to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. We are going to summarize the test performance using random effects models.Results:Based on the pooled sensitivity, specificity, and diagnostic accuracy, we intend to provide the relative diagnostic efficiency in ICC through RS.Conclusion:Through this systematic review and meta-analysis, we intend to provide the pooled sensitivity, specificity and diagnostic accuracy of RS in the diagnosis of suspected ICC. Other parameters like positive likelihood ratios (LR), negative LR, diagnostic odds ratio (DOR), and area under curve (AUC) of the summary receiver operating characteristics (SROC) curve will also be calculated and related figures will be drawn to help illustrate the efficacy of RS in the diagnosis of ICC. 相似文献
5.
目的:探讨Zeste基因增强子(enhancer of zeste homolog 2,EZH2)对弥漫大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)RCHOP方案治疗的效果的预测价值。方法:纳入2017年1月至2018年5月南华大学附属第二医院80例接受RCHOP方案治疗的DLBCL患者,分析患者EZH2表达情况与治疗效果的关系,绘制EZH2预测治疗效果的ROC曲线,并对患者pCR与病理特征的关系进行讨论。结果:80例患者中EZH2高表达者49例,EZH2低表达者31例,DLBCL患者RCHOP治疗的pCR率为51.25%,其中EZH2高表达患者完全缓解(complete response,CR)、客观缓解率(objective response rate,ORR)均明显低于EZH2低表达患者(P<0.05);EZH2预测治疗效果的曲线下面积为0.874(P<0.05);pCR与性别、年龄、美国东部肿瘤协作组(Eastern Cooperative Oncology Group,ECOG)得分、淋巴瘤国际预后指数(International Prognostic Index,IPI)得分、乳酸脱氢酶(lactate dehydrogenase,LDH)因素无相关关系(P>0.05);与Hans分型、EZH2表达水平存在一定的相关性(P<0.05)。结论:DLBCL患者EZH2低表达是RCHOP治疗后高pCR率的预测因子,在临床上有助于为DLBCL患者临床治疗提供更好的指导。 相似文献
6.
High Temperamental Negative Affectivity in early childhood has been found to predict later emotion dysregulation. While much work has been conducted to separately probe bio-behavioral systems associated with Negative Affectivity, very little work has examined the relations among multiple systems across age. In this study, we use multi-modal methods to index neurobiological systems associated with Negative Affectivity in 53 4-7-year-old children. Prefrontal activation during emotion regulation was measured using functional near-infrared spectroscopy over the lateral prefrontal cortex (PFC) while children played a game designed to elicit frustration in Social (Happy and Angry faces) and Nonsocial contexts. Gaze behaviors while free-viewing Happy and Angry faces were also measured. Finally, Negative Affectivity was indexed using a score composite based on factor analysis of parent-reported temperament. Using mixed-effects linear models, we found an age-dependent association between Negative Affectivity and both PFC activation during frustration and fixation duration on the mouth area of Happy faces, such that older children high in Negative Affectivity spent less time looking at the mouths of Happy faces and had lower PFC activation in response to frustration (ps<0.034). These results provide further insight to how Negative Affectivity may be associated with changes in affective neurobiological systems across early childhood. 相似文献
7.
8.
目的:探讨溴结构域和超末端结构域(bromodomain and extra terminal domain,BET)抑制剂对弥漫性大B细胞淋巴瘤CRL-2630细胞生长的影响,以及对弥漫性大B细胞淋巴瘤BALB/c-nu裸鼠外周血中辅助性T细胞17(helper T cells,Th17)数量和相关细胞因子表达的影响。方法:培养弥漫性大B细胞淋巴瘤株CRL-2630,使用不同浓度BET抑制剂(2、4、8、16、32 nmol/L)处理48 h,32 nmol/L BET抑制剂处理不同时间(12、24、36、48 h),CCK-8法检测各处理细胞活性;集落形成实验检测不同BET抑制剂浓度处理后细胞集落形成能力;Annexin V-FITC/PI双染法检测不同BET抑制剂浓度处理后细胞凋亡情况;实时荧光定量PCR与Western blot检测32 nmol/L BET抑制剂处理CRL-2630细胞48 h后HMGA1 mRNA与蛋白的表达水平;构建HMGA1过表达载体并通过脂质体介导法转染CRL-2630细胞,并用32 nmol/L BET抑制剂处理48 h,检测细胞活性与凋亡情况;构建裸鼠弥漫性大B细胞淋巴瘤模型并采集外周血,流式细胞术检测Th17细胞比例,ELISA法检测相关细胞因子的含量。结果:在一定范围内,BET抑制剂呈剂量依赖性地抑制CRL-2630细胞的活性,32 nmol/L BET抑制剂以时间依赖性地抑制CRL-2630细胞的活性。随着BET抑制剂处理浓度的增高,CRL-2630细胞集落形成能力逐渐下降,凋亡率逐渐升高。32 nmol/L BET抑制剂处理CRL-2630细胞48 h后,细胞中HMGA1的mRNA和蛋白水平均明显下降。pcDNA3.4-HMGA1转染CRL-2630细胞再使用BET抑制剂处理后,细胞的活性升高而凋亡率明显下降。弥漫性大B细胞淋巴瘤裸鼠经BET抑制剂作用后,外周血Th17细胞比例和IL-6、IL-17、IL-23含量较生理盐水组明显下降。结论:BET抑制剂能有效抑制 CRL-2630细胞活性,并诱导其凋亡,在一定范围内呈时效和量效关系。BET抑制剂还可以抑制弥漫性大B细胞淋巴瘤裸鼠外周血Th17细胞数量和相关细胞炎性因子的分泌,其作用机制可能与HMGA1的表达下调有关。 相似文献
9.
10.
目的:探讨中性粒细胞/淋巴细胞比值(neutrophil to lymphocyte ratio,NLR)对初治前弥漫性大B细胞淋巴瘤(diffuse large B cell lymphoma,DLBCL)患者预后的意义。方法:回顾性分析2010年1月至2019年10月,新疆医科大学附属肿瘤医院收治的165例初治DLBCL患者,确定了NLR(>2.77)在预后预测中的最佳临界值,采用Log-rank检验和Cox回归模型进行分析,评价治疗前NLR对无进展生存期(progression free survival time,PFS)和总生存期(overall survival rate,OS)的影响。结果:在入选的165例患者中,有67例患者治疗前NLR升高(>2.77),NLR升高与PFS和OS较短的患者明显相关(P<0.001和P=0.003)。多变量分析进一步表明,NLR>2.77是PFS的独立预测因子。结论:治疗前NLR升高提示DLBCL患者预后不良。 相似文献